California Department of Public Health

With the California licensure, the company’s PCR-based Colvera colorectal cancer monitoring test is available in all US states except New York.

The decision opens up the largest market in the country to the firm's lymphoma and leukemia testing services.

NEW YORK (GenomeWeb News) – Silicon Valley Biosystems today said that its in silico diagnostics laboratory has received CLIA certification from the California Department of Public Health.

"Most of the benefit of this program has already been had," said a UC Berkeley genetics professor after the California Department of Public Health limited the scope of the university's educational genetic testing project because it determined it was providing medical information.

The California Department of Public Health has said that part of the school's plan to test the DNA of incoming freshmen for three gene variants is not allowed by CLIA law, but the school hopes that lessons will be learned anyway.

BioArray Briefs

Premium

CGC Genetics, Nuvera Biosciences, Veridex, ImaGenes, CapitalBio, Fisher Healthcare, Osmetech, National Institutes of Health, Clinical Data, Cogenics, UK Biotechnology and Biological Sciences Research Council

Navigenics’ lower-priced program to incorporate genetic risk data in patients’ annual medical checkup raises questions as to whether personal genomics firms should be broadly marketing their services to physicians.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.